BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20502866)

  • 1. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial.
    Barraud D; Blard C; Hein F; Marçon O; Cravoisy A; Nace L; Alla F; Bollaert PE; Gibot S
    Intensive Care Med; 2010 Sep; 36(9):1540-7. PubMed ID: 20502866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trial.
    Cook DJ; Johnstone J; Marshall JC; Lauzier F; Thabane L; Mehta S; Dodek PM; McIntyre L; Pagliarello J; Henderson W; Taylor RW; Cartin-Ceba R; Golan E; Herridge M; Wood G; Ovakim D; Karachi T; Surette MG; Bowdish DM; Lamarche D; Verschoor CP; Duan EH; Heels-Ansdell D; Arabi Y; Meade M;
    Trials; 2016 Aug; 17():377. PubMed ID: 27480757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
    Johnstone J; Meade M; Lauzier F; Marshall J; Duan E; Dionne J; Arabi YM; Heels-Ansdell D; Thabane L; Lamarche D; Surette M; Zytaruk N; Mehta S; Dodek P; McIntyre L; English S; Rochwerg B; Karachi T; Henderson W; Wood G; Ovakim D; Herridge M; Granton J; Wilcox ME; Goffi A; Stelfox HT; Niven D; Muscedere J; Lamontagne F; D'Aragon F; St-Arnaud C; Ball I; Nagpal D; Girard M; Aslanian P; Charbonney E; Williamson D; Sligl W; Friedrich J; Adhikari NK; Marquis F; Archambault P; Khwaja K; Kristof A; Kutsogiannis J; Zarychanski R; Paunovic B; Reeve B; Lellouche F; Hosek P; Tsang J; Binnie A; Trop S; Loubani O; Hall R; Cirone R; Reynolds S; Lysecki P; Golan E; Cartin-Ceba R; Taylor R; Cook D;
    JAMA; 2021 Sep; 326(11):1024-1033. PubMed ID: 34546300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.
    Morrow LE; Kollef MH; Casale TB
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1058-64. PubMed ID: 20522788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.
    Lau VI; Cook DJ; Fowler R; Rochwerg B; Johnstone J; Lauzier F; Marshall JC; Basmaji J; Heels-Ansdell D; Thabane L; Xie F;
    BMJ Open; 2020 Jun; 10(6):e036047. PubMed ID: 32595159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial.
    Honeycutt TC; El Khashab M; Wardrop RM; McNeal-Trice K; Honeycutt AL; Christy CG; Mistry K; Harris BD; Meliones JN; Kocis KC
    Pediatr Crit Care Med; 2007 Sep; 8(5):452-8; quiz 464. PubMed ID: 17693918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients.
    Forestier C; Guelon D; Cluytens V; Gillart T; Sirot J; De Champs C
    Crit Care; 2008; 12(3):R69. PubMed ID: 18489775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial.
    Mahmoodpoor A; Hamishehkar H; Asghari R; Abri R; Shadvar K; Sanaie S
    Nutr Clin Pract; 2019 Feb; 34(1):156-162. PubMed ID: 30088841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT.
    Johnstone J; Heels-Ansdell D; Thabane L; Meade M; Marshall J; Lauzier F; Duan EH; Zytaruk N; Lamarche D; Surette M; Cook DJ;
    BMJ Open; 2019 Jun; 9(6):e025228. PubMed ID: 31227528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the effects of probiotics on various parameters in critically ill ventilated individuals.
    Wang B; Xie J; Teng Y
    Adv Clin Exp Med; 2023 Jun; 32(6):633-642. PubMed ID: 36924217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial.
    Banupriya B; Biswal N; Srinivasaraghavan R; Narayanan P; Mandal J
    Intensive Care Med; 2015 Apr; 41(4):677-85. PubMed ID: 25708419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial.
    Shimizu K; Yamada T; Ogura H; Mohri T; Kiguchi T; Fujimi S; Asahara T; Yamada T; Ojima M; Ikeda M; Shimazu T
    Crit Care; 2018 Sep; 22(1):239. PubMed ID: 30261905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Effect of Probiotics on Cytokine Levels in Critically Ill Children With Severe Sepsis: A Double-Blind, Placebo-Controlled Trial.
    Angurana SK; Bansal A; Singhi S; Aggarwal R; Jayashree M; Salaria M; Mangat NK
    Crit Care Med; 2018 Oct; 46(10):1656-1664. PubMed ID: 29957709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: randomized controlled trial.
    Ferrie S; Daley M
    JPEN J Parenter Enteral Nutr; 2011 Jan; 35(1):43-9. PubMed ID: 20978244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis.
    Lau VI; Xie F; Fowler RA; Rochwerg B; Johnstone J; Lauzier F; Marshall JC; Basmaji J; Henderson W; Khwaja K; Loubani O; Niven DJ; Zarychanski R; Arabi YM; Cartin-Ceba R; Thabane L; Heels-Ansdell D; Cook DJ
    Can J Anaesth; 2022 Dec; 69(12):1515-1526. PubMed ID: 36289153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection.
    Lewis SR; Schofield-Robinson OJ; Rhodes S; Smith AF
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012248. PubMed ID: 31476022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial.
    Zeng J; Wang CT; Zhang FS; Qi F; Wang SF; Ma S; Wu TJ; Tian H; Tian ZT; Zhang SL; Qu Y; Liu LY; Li YZ; Cui S; Zhao HL; Du QS; Ma Z; Li CH; Li Y; Si M; Chu YF; Meng M; Ren HS; Zhang JC; Jiang JJ; Ding M; Wang YP
    Intensive Care Med; 2016 Jun; 42(6):1018-28. PubMed ID: 27043237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial.
    Knight DJ; Gardiner D; Banks A; Snape SE; Weston VC; Bengmark S; Girling KJ
    Intensive Care Med; 2009 May; 35(5):854-61. PubMed ID: 19083199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.
    Manzanares W; Lemieux M; Langlois PL; Wischmeyer PE
    Crit Care; 2016 Aug; 19():262. PubMed ID: 27538711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-probiotic preparation for ventilator-associated pneumonia in multi-trauma patients: results of a randomized clinical trial.
    Tsilika M; Thoma G; Aidoni Z; Tsaousi G; Fotiadis K; Stavrou G; Malliou P; Chorti A; Massa H; Antypa E; Vasiliadou G; Pagdatoglou K; Voudouris A; Vasiliagou S; Mitos G; Kontopoulou N; Paraforou N; Antoniadou E; Mouloudi H; Gkeka E; Grosomanidis V; Giamarellos-Bourboulis EJ; Kotzampassi K
    Int J Antimicrob Agents; 2022 Jan; 59(1):106471. PubMed ID: 34757134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.